# The Vienna Prograf and Endothelial Progenitor Cell Extension Study

> **NCT03751332** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 87 (actual)

## Conditions studied

- Immunosuppression
- Renal Failure

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT03751332
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2018-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03751332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03751332, "The Vienna Prograf and Endothelial Progenitor Cell Extension Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03751332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*